COVID-19 Healthcare Planning: Predicting Mortality and the Role of the Herd Immunity Barrier in the General Population

[EN] Using a mathematical model for COVID-19 incorporating data on excess of mortality compared to the corresponding period of the previous year obtained from the daily monitoring of mortality in Spain (MoMo), the prediction of total number of casualties in Spain for the first outbreak has been computed. From this figure, and following a stepwise meta-analysis of available reports, the case fatality rate (CFR) and the infectious case fatality rate (IFR) for the outbreak have been estimated. As the impact of age on these rates is notable, it is proposed to include an age-related adjusted fatality ratio in future comparative analyses between studies, calculated by adjusting the results by risk ratio to a reference age band (e.g., 60-69). From the casualty figures, and the corresponding CFR and IFR ratios, the forecast of serologically positive cases in the general Spanish population has been estimated at approximately 1% (0.87-1.3%) of the samples. If the data are confirmed by the ongoing study of the Carlos III Institute, until a vaccine is found, the immunity acquired in the general population after the infectious outbreak is far from the 65-70% herd immunity required as a barrier for COVID-19.Marco-Franco, JE.; Guadalajara Olmeda, MN.; González-De Julián, S.; Vivas-Consuelo, D. (2020). COVID-19 Healthcare Planning: Predicting Mortality and the Role of the Herd Immunity Barrier in the General Population. Sustainability. 12(13):1-10. https://doi.org/10.3390/su121352281101213Mathematical modeling draws more accurate picture of coronavirus cases 2020https://www.eurekalert.org/pub_releases/2020-04/mcog-mmd041020.phpRed Nacional de Vigilancia Epidemiológica-[Spanish epidemiological surveillance network]https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/Documents/INFORMES/Informes%20COVID-19/Informe%20nº%2022.%20Situación%20de%20COVID-19%20en%20España%20a%2013%20de%20abril%20de%202020.pdfJung, S., Akhmetzhanov, A. R., Hayashi, K., Linton, N. M., Yang, Y., Yuan, B., … Nishiura, H. (2020). Real-Time Estimation of the Risk of Death from Novel Coronavirus (COVID-19) Infection: Inference Using Exported Cases. Journal of Clinical Medicine, 9(2), 523. doi:10.3390/jcm9020523Linton, N., Kobayashi, T., Yang, Y., Hayashi, K., Akhmetzhanov, A., Jung, S., … Nishiura, H. (2020). Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data. Journal of Clinical Medicine, 9(2), 538. doi:10.3390/jcm9020538Rajgor, D. D., Lee, M. H., Archuleta, S., Bagdasarian, N., & Quek, S. C. (2020). The many estimates of the COVID-19 case fatality rate. The Lancet Infectious Diseases, 20(7), 776-777. doi:10.1016/s1473-3099(20)30244-9Mizumoto, K., Kagaya, K., Zarebski, A., & Chowell, G. (2020). Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Eurosurveillance, 25(10). doi:10.2807/1560-7917.es.2020.25.10.2000180Wu, J. T., Leung, K., Bushman, M., Kishore, N., Niehus, R., de Salazar, P. M., … Leung, G. M. (2020). Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Nature Medicine, 26(4), 506-510. doi:10.1038/s41591-020-0822-7Hauser, A., Counotte, M. J., Margossian, C. C., Konstantinoudis, G., Low, N., Althaus, C. L., & Riou, J. (2020). Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: a modeling study in Hubei, China, and six regions in Europe. doi:10.1101/2020.03.04.20031104Russell, T. W., Hellewell, J., Jarvis, C. I., van Zandvoort, K., Abbott, S., … Ratnayake, R. (2020). Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020. Eurosurveillance, 25(12). doi:10.2807/1560-7917.es.2020.25.12.2000256Wu, Z., & McGoogan, J. M. (2020). Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China. JAMA, 323(13), 1239. doi:10.1001/jama.2020.2648Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., … Zhang, L. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet, 395(10223), 507-513. doi:10.1016/s0140-6736(20)30211-7Wang, X., Ma, Z., Ning, Y., Chen, C., Chen, R., Chen, Q., … Zhao, H. (2020). Estimating the case fatality ratio of the COVID-19 epidemic in China. doi:10.1101/2020.02.17.20023630Italian Task Force COVID-19. Epidemia COVID-19 [Covid-19 epidemic]https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino-sorveglianza-integrata-COVID-19_26-marzo%202020.pdfUK coronavirus death toll reaches 1,789 amid data reporting concerns |World news| The Guardianhttps://www.theguardian.com/world/2020/mar/31/uk-coronavirus-death-toll-reaches-1789-amid-data-reporting-concernsCoronavirus-missing-deathshttps://www.nytimes.com/interactive/2020/04/21/world/coronavirus-missing-deaths.htmlLipsitch, M., Cohen, T., Cooper, B., Robins, J. M., Ma, S., James, L., … Murray, M. (2003). Transmission Dynamics and Control of Severe Acute Respiratory Syndrome. Science, 300(5627), 1966-1970. doi:10.1126/science.1086616Sanche, S., Lin, Y. T., Xu, C., Romero-Severson, E., Hengartner, N., & Ke, R. (2020). High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2. Emerging Infectious Diseases, 26(7), 1470-1477. doi:10.3201/eid2607.200282WHO warns that few have developed antibodies to Covid-19https://www.theguardian.com/society/2020/apr/20/studies-suggest-very-few-have-had-covid-19-without-symptomsVerity, R., Okell, L. C., Dorigatti, I., Winskill, P., Whittaker, C., Imai, N., … Ferguson, N. M. (2020). Estimates of the severity of COVID-19 disease. doi:10.1101/2020.03.09.20033357Wong, J. Y., Kelly, H., Ip, D. K. M., Wu, J. T., Leung, G. M., & Cowling, B. J. (2013). Case Fatality Risk of Influenza A (H1N1pdm09). Epidemiology, 24(6), 830-841. doi:10.1097/ede.0b013e3182a67448Bendavid, E., Mulaney, B., Sood, N., Shah, S., Ling, E., Bromley-Dulfano, R., … Bhattacharya, J. (2020). COVID-19 Antibody Seroprevalence in Santa Clara County, California. doi:10.1101/2020.04.14.2006246